Enveric Biosciences Inc (ENVB) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $2.32
• Market Cap: $2.83M
• EPS: $-119.64
• 52-Week High: $37.20
• 52-Week Low: $1.96

Market Sentiment

Enveric Biosciences Inc currently has a Bullish sentiment score of 0.56.

About Enveric Biosciences Inc

Enveric Biosciences Inc. is a pioneering pharmaceutical company based in Florida, dedicated to developing cannabinoid-based therapeutics that significantly improve treatment outcomes for cancer patients. By leveraging its deep expertise in cannabinoid research, Enveric is focused on creating innovative drug candidates that target unmet medical needs and enhance the quality of life for individuals battling cancer. With a strong emphasis on clinical development, the company is strategically pos...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Enveric Biosciences Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does ENVB pay dividends?

Enveric Biosciences Inc (ENVB) does not currently pay a regular dividend.

What is ENVB's market cap?

Enveric Biosciences Inc (ENVB) has a market capitalization of $2.83M with a current stock price of $2.32.